Cyberkinetics Inc.'s Neural Sensing Technology Highlighted In Second Study Published In Nature

FOXBOROUGH, Mass.--(BUSINESS WIRE)--July 13, 2006--Cyberkinetics Neurotechnology Systems, Inc. (OTCBB: CYKN; "Cyberkinetics") announced today that preclinical results reported by a team of researchers from Stanford University's Schools of Engineering and Medicine were published in the July 13, 2006, issue of the journal Nature. Scientific findings from the first participant in the Company's ongoing pilot clinical trials of the BrainGate Neural Interface System (BrainGate) were featured on the cover of the same issue. The Stanford team used Cyberkinetics' research products line of neural interface technology to demonstrate the ability to obtain accurate, high-speed neural recordings that can immediately be translated into a prediction of intended movement. This research underscores the feasibility for using neural signals as the basis for brain-computer interfaces (BCI) that could be developed to enable those with nervous system injuries or diseases to operate external devices that require fast, accurate selections, such as typing.